Literature DB >> 16097050

Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis.

Hong-Li Jiang1, Wu-Jun Xue, Da-Qing Li, Ai-Ping Yin, Xia Xin, Chun-Mei Li, Ju-Lin Gao.   

Abstract

AIM: To investigate whether continuous veno-venous hemofiltration (CVVH) in different filtration rate to eliminate cytokines would result in different efficiency in acute pancreatitis, whether the saturation time of filter membrane was related to different filtration rate, and whether the onset time of CVVH could influence the survival of acute pancreatitis.
METHODS: Thirty-seven patients were classified into four groups randomly. Group 1 underwent low-volume CVVH within 48 h of the onset of abdominal pain (early CVVH, n = 9). Group 2 received low-volume CVVH after 96 h of the onset of abdominal pain (late CVVH, n = 10). Group 3 underwent high-volume CVVH within 48 h of the onset of abdominal pain (early CVVH, n = 9). Group 4 received high-volume CVVH after 96 h of the onset of abdominal pain (late CVVH, n = 9). CVVH was sustained for at least 72 h. Blood was taken before hemofiltration, and ultrafiltrate was collected at the start of CVVH and every 12 h during CVVH period for the purpose of measuring the concentrations of TNF-alpha, IL-1beta and IL-6. The concentrations of TNF-alpha, IL-1beta and IL-6 were measured by swine-specific ELISA. The Solartron 1 255 B frequency response analyzer (British) was used to observe the resistance of filter membrane.
RESULTS: The survival rate had a significant difference (94.44% vs 68.42%, P<0.01) high-volume and low-volume CVVH patients. The survival rate had also a significant difference (88.89% vs 73.68%, P<0.05) between early and late CVVH patients. The hemodynamic deterioration (MAP, HR, CVP) was less severe in groups 4 and 1 than that in group 2, and in group 3 than in group 4. The adsorptive saturation time of filters membranes was 120-180 min if the filtration rate was 1 000-4 000 mL/h. After the first, second and third new hemofilters were changed, serum TNF-alpha concentrations had a negative correlation with resistance (r: -0.91, -0.89, and -0.86, respectively in group 1; -0.89, -0.85, and -0.76, respectively in group 2; -0.88, -0.92, and -0.82, respectively in group 3; -0.84, -0.87, and -0.79, respectively in group 4). The decreasing extent of TNF-alpha, IL-1beta and IL-6 was significantly different between group 3 and group 1 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.01), between group 4 and group 2 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.01), between group 1 and group 2 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.05), and between group 3 and group 4 (TNF-alpha P<0.01, IL-1beta P<0.01, IL-6 P<0.05), respectively during CVVH period. The decreasing extent of TNF-alpha and IL-1beta was also significantly different between survival patients and dead patients (TNF-alpha P<0.05, IL-1beta P<0.05). In survival patients, serum concentration of TNF-alpha and IL-1beta decreased more significantly than that in dead patients.
CONCLUSION: High-volume and early CVVH improve hemodynamic deterioration and survival in acute pancreatitis patients. High-volume CVVH can eliminate cytokines more efficiently than low-volume CVVH. The survival rate is related to the decrease extent of TNF-alpha and IL-1beta. The adsorptive saturation time of filter membranes are different under different filtration rate condition. The filter should be changed timely once filter membrane adsorption is saturated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097050      PMCID: PMC4398728          DOI: 10.3748/wjg.v11.i31.4815

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Blood purification in non-renal critical illness.

Authors:  John A Kellum; Rinaldo Bellomo; Ravindra Mehta; Claudio Ronco
Journal:  Blood Purif       Date:  2003       Impact factor: 2.614

2.  Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.

Authors:  E F Yekebas; C F Eisenberger; H Ohnesorge; A Saalmüller; H A Elsner; M Engelhardt; A Gillesen; J Meins; M The; T Strate; C Busch; W T Knoefel; C Bloechle; J R Izbicki
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.

Authors:  C Tetta; F Mariano; J Buades; C Ronco; M L Wratten; G Camussi
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

4.  Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms.

Authors:  Eizo Watanabe; Hiroyuki Hirasawa; Shigeto Oda; Kenichi Matsuda; Masahiko Hatano; Takeshi Tokuhisa
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

5.  Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.

Authors:  G Lonnemann; K M Koch; S Shaldon; C A Dinarello
Journal:  J Lab Clin Med       Date:  1988-07

6.  Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis.

Authors:  C B Hughes; L W Gaber; A B Mohey el-Din; H P Grewal; M Kotb; L Mann; A O Gaber
Journal:  Am Surg       Date:  1996-01       Impact factor: 0.688

7.  Acute pancreatitis induces cytokine production in endotoxin-resistant mice.

Authors:  J W Eubanks; O Sabek; M Kotb; L W Gaber; J Henry; N Hijiya; L G Britt; A O Gaber; S M Goyert
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

8.  Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration.

Authors:  C Ronco; C Tetta; A Lupi; E Galloni; M C Bettini; L Sereni; F Mariano; A DeMartino; G Montrucchio; G Camussi
Journal:  Crit Care Med       Date:  1995-01       Impact factor: 7.598

9.  Membrane adsorption of beta 2-microglobulin: equilibrium and kinetic characterization.

Authors:  W R Clark; W L Macias; B A Molitoris; N H Wang
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

10.  Renal failure in acute pancreatitis. Timing of dialysis and surgery.

Authors:  G Pupelis
Journal:  Przegl Lek       Date:  2000
View more
  11 in total

1.  Conservative approach in the management of severe acute pancreatitis: eight-year experience in a single institution.

Authors:  G Pupelis; K Zeiza; H Plaudis; A Suhova
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 2.  Continuous veno-venous hemofiltration for severe acute pancreatitis.

Authors:  Yanjun Lin; Sirong He; Junhua Gong; Xiong Ding; Zuojin Liu; Jianping Gong; Zhong Zeng; Yao Cheng
Journal:  Cochrane Database Syst Rev       Date:  2019-10-16

Review 3.  Fluid resuscitation in acute pancreatitis.

Authors:  Aakash Aggarwal; Manish Manrai; Rakesh Kochhar
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  AKI Associated with Acute Pancreatitis.

Authors:  Tareq I Nassar; Wajeh Y Qunibi
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-22       Impact factor: 8.237

5.  Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience.

Authors:  G Pupelis; H Plaudis; A Grigane; K Zeiza; G Purmalis
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 6.  Clinical review: blood purification for sepsis.

Authors:  Thomas Rimmelé; John A Kellum
Journal:  Crit Care       Date:  2011-02-16       Impact factor: 9.097

7.  Timing of renal replacement therapy initiation for acute kidney injury.

Authors:  Alicia Isabel I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

8.  Early continuous veno-venous haemofiltration in the management of severe acute pancreatitis complicated with intra-abdominal hypertension: retrospective review of 10 years' experience.

Authors:  Guntars Pupelis; Haralds Plaudis; Kaspars Zeiza; Nadezda Drozdova; Maksims Mukans; Ita Kazaka
Journal:  Ann Intensive Care       Date:  2012-12-20       Impact factor: 6.925

Review 9.  Intensity of continuous renal replacement therapy for acute kidney injury.

Authors:  Alicia I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

10.  PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration.

Authors:  Gaku Akashita; Yuto Hosaka; Toru Noda; Kazuya Isoda; Tsutomu Shimada; Kazuki Sawamoto; Ken-Ichi Miyamoto; Takumi Taniguchi; Yoshimichi Sai
Journal:  J Pharm Health Care Sci       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.